Personalized psychiatry meds using gene test results
Part of Mental health clinical trials.
This study compares a personalized medication plan based on your genes versus standard dosing for people with depression, anxiety, or psychosis. It may help your clinician choose a safer or more effective dose or medicine by using pharmacogenomics (gene-informed prescribing).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re currently having a depressive episode, anxiety disorder, or a psychotic disorder
- You tried at least one past psychiatric medicine but it didn’t work enough or you couldn’t tolerate it
- You are starting (or already switched within 2 weeks) to sertraline/escitalopram, or aripiprazole/risperidone
- You’re able to consent and agree to let the study use your medical records
- You can use a smartphone app for passive monitoring
- You’re age 16 to under 70
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether genes (using a saliva sample) can help explain why some young people feel more “disinhibited” after taking antidepressants like SSRIs. If you’ve had depression, anxiety, or OCD and have used an SSRI, your information and genetics may help improve how antidepressants are chosen and monitored.
This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.
This trial tests whether a genetic test (pharmacogenomics) can help doctors choose better medications for people with schizophrenia. If you've had side effects or your symptoms haven't improved with your current antipsychotic, this study may help find a treatment that works better for you.
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
Hear when a new Mood Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.